Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Anika Therapeutics (ANIK) Asset Utilization Ratio (2016 - 2025)

Anika Therapeutics (ANIK) has disclosed Asset Utilization Ratio for 15 consecutive years, with 0.59 as the latest value for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio changed 0.08% to 0.59 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.59, a 0.08% change, with the full-year FY2025 number at 0.57, up 13.33% from a year prior.
  • Asset Utilization Ratio was 0.59 for Q4 2025 at Anika Therapeutics, down from 0.6 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.65 in Q2 2025 to a low of 0.33 in Q4 2022.
  • A 5-year average of 0.45 and a median of 0.41 in 2021 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: decreased 23.22% in 2023, then surged 75.15% in 2025.
  • Anika Therapeutics' Asset Utilization Ratio stood at 0.42 in 2021, then fell by 22.59% to 0.33 in 2022, then increased by 23.5% to 0.4 in 2023, then skyrocketed by 47.41% to 0.59 in 2024, then decreased by 0.08% to 0.59 in 2025.
  • Per Business Quant, the three most recent readings for ANIK's Asset Utilization Ratio are 0.59 (Q4 2025), 0.6 (Q3 2025), and 0.65 (Q2 2025).